31 Oct 2017
Innovation, Application, Commercialisation
This content is only available within our institutional offering.
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Innovation, Application, Commercialisation
Allergy Therapeutics plc (AGY:LON) | 2.8 0 (-1.8%) | Mkt Cap: 133.5m
- Published:
31 Oct 2017 -
Author:
Dr Mike Mitchell -
Pages:
17